Myriad Genetics reported $947.4M in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -61964000 5.19M
Becton, Dickinson and BDX:US $ 25493M 968M
Bio Rad Laboratories BIO:US $ 8922.6M 1260.32M
Biocept BIOC:US $ 37.03M 0.45M
Bruker BRKR:US $ 984.4M 32.6M
Danaher DHR:US $ 46594M 238M
Exact Sciences EXAS:US $ 3209.35M 48.86M
Hologic HOLX:US $ 4997.9M 205.2M
Illumina ILMN:US $ 10444M 451M
Mettler Toledo International MTD:US 7.26M 77.31M
Myriad Genetics MYGN:US $ 947.4M 2.7M
Nanostring Technologies NSTG:US $ 112.66M 32.64M
Orasure Technologies OSUR:US $ 344.19M 20.69M
Perkinelmer PKI:US $ 7167.16M 19.19M
Quest Diagnostics DGX:US $ 6411M 34M
Quidel QDEL:US $ 4919.6M 2504.68M
Repligen RGEN:US $ 1805.36M 38.96M
Thermo Fisher Scientific TMO:US $ 42354M 1398M
Veracyte VCYT:US $ 1064.15M 21.04M
Waters WAT:US $ 392.12M 17.19M